Matinas BioPharma Holdings, Inc. (AMEX:MTNB) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.
Matinas BioPharma Holdings, Inc.'s stock currently trades at $0.72 with a market capitalization of $4.4M. The Healthcare company's stock moved following the disclosure.